Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Clinical chemistry and laboratory medicine - 60(2021), 1 vom: 02. Sept., Seite e1-e3 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lippi, Giuseppe [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Anmerkungen: |
© 2021 Walter de Gruyter GmbH, Berlin/Boston |
|---|
| doi: |
10.1515/cclm-2021-0848 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2142469752 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2142469752 | ||
| 003 | DE-627 | ||
| 005 | 20231205151644.0 | ||
| 007 | tu | ||
| 008 | 230813s2021 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1515/cclm-2021-0848 |2 doi | |
| 035 | |a (DE-627)OLC2142469752 | ||
| 035 | |a (DE-B1597)cclm-2021-0848-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |a 540 |q VZ |
| 082 | 0 | 4 | |a 540 |a 610 |q VZ |
| 100 | 1 | |a Lippi, Giuseppe |e verfasserin |0 (orcid)0000-0001-9523-9054 |4 aut | |
| 245 | 1 | 0 | |a Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © 2021 Walter de Gruyter GmbH, Berlin/Boston | ||
| 700 | 1 | |a Sanchis-Gomar, Fabian |4 aut | |
| 700 | 1 | |a Henry, Brandon M. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical chemistry and laboratory medicine |d De Gruyter, 1998 |g 60(2021), 1 vom: 02. Sept., Seite e1-e3 |w (DE-627)240770250 |w (DE-600)1418007-8 |w (DE-576)064883795 |x 1434-6621 |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2021 |g number:1 |g day:02 |g month:09 |g pages:e1-e3 |
| 856 | 4 | 1 | |u https://doi.org/10.1515/cclm-2021-0848 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_4219 | ||
| 912 | |a GBV_ILN_4277 | ||
| 951 | |a AR | ||
| 952 | |d 60 |j 2021 |e 1 |b 02 |c 09 |h e1-e3 | ||